跳至主要内容
临床试验/NCT04289038
NCT04289038已完成不适用

Evaluation of the Efficacy of VR and AR on Pruritus Symptoms in Patients Receiving Hemodialysis Treatment

Hacettepe University2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
2
主要终点
5-D Itch Scale

研究概览

简要总结

The research will be conducted randomly in order to determine the effect of VR and AR on pruritus symptom.

详细描述

In this study, there will be three groups: intervention group 1 with autogenic relaxation (AR), intervention group 2 with virtual reality (VR) game application and control group with routine nursing care and kidney functions narration. The number of volunteers to be included in the study was determined by power analysis. Forty patients with itch symptoms will be included in each group. Preliminary application for all three groups will be performed in the patient group registered to the Dialysis Unit of the Nephrology Department of Hacettepe University and Baskent University Hospital. Socio-Demographic Form, 5-D Itch Scale, Dermatology Life Quality Index, State and Trait Anxiety Scale, Pruritus Behavior and SGO / OR Application Log.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving hemodialysis treatment for the last 6 months,
  • Receiving four hour hemodialysis treatment three times a week,
  • 18-65 years of age,
  • experiencing pruritus for the last month.
  • Not taking any pharmacological / non-pharmacological treatment for pruritus
  • No cognitive and psychiatric diagnosis,
  • Do not use hearing aids,
  • Open to communication and cooperation,
  • Using smart mobile phone,
  • Without liver disease and dermatological diseases,
  • Patients who agree to participate in the study will be included in the study.

排除标准

  • Pregnant in the research process,
  • Kidney transplantation,
  • Experiencing discomfort due to virtual reality glasses,
  • Patients who voluntarily leave the trial will be excluded from the follow-up.

结局指标

主要结局

5-D Itch Scale

时间窗: Assessing change of 5-D Itch Scale scores baseline, first, fifth and seventh weeks.

The score obtained from information about itching severity, frequency, and its effect on daily life activities.

次要结局

  • State-Trait Anxiety Inventory(Assessing change of State-Trait Anxiety Inventory scores baseline, first, fifth and seventh weeks.)
  • Dermatology Life Quality Index(Assessing change of Dermatology Life Quality Index scores baseline, first, fifth and seventh weeks. .)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Neşe Altinok Ersoy

MS, Research Assistant, Principal Investigator

Hacettepe University

研究点 (2)

Loading locations...

相似试验